M
Maurice Buchbinder
Researcher at Stanford University
Publications - 71
Citations - 6987
Maurice Buchbinder is an academic researcher from Stanford University. The author has contributed to research in topics: Stent & Restenosis. The author has an hindex of 29, co-authored 63 publications receiving 5998 citations. Previous affiliations of Maurice Buchbinder include Scripps Health & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
David R. Holmes,Vivek Y. Reddy,Zoltan G. Turi,Shephal K. Doshi,Horst Sievert,Maurice Buchbinder,Christopher M. Mullin,Peter Sick +7 more
TL;DR: The efficacy of percutaneous closure of the LAA with this device was non-inferior to that of warfarin therapy and there was a higher rate of adverse safety events in the intervention group than in the control group, which were mainly a result of periprocedural complications.
Journal ArticleDOI
Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation A Randomized Clinical Trial
Vivek Y. Reddy,Horst Sievert,Jonathan L. Halperin,Shephal K. Doshi,Maurice Buchbinder,Petr Neuzil,Kenneth C. Huber,Brian Whisenant,Saibal Kar,Vijay Swarup,Nicole Gordon,David R. Holmes,Investigators +12 more
TL;DR: Percutaneous LAA closure met criteria for both noninferiority and superiority, compared with warfarin, for preventing the combined outcome of stroke, systemic embolism, and cardiovascular death, as well as superiority for cardiovascular and all-cause mortality.
Journal ArticleDOI
5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials
Vivek Y. Reddy,Shephal K. Doshi,Saibal Kar,Douglas N. Gibson,Matthew J. Price,Kenneth Huber,Rodney Horton,Maurice Buchbinder,Petr Neuzil,Nicole Gordon,David R. Holmes,Prevail,Protect Af Investigators +12 more
TL;DR: It is demonstrated that LAAC with Watchman provides stroke prevention in nonvalvular atrial fibrillation comparable to warfarin, with additional reductions in major bleeding, particularly hemorrhagic stroke, and mortality.
Journal ArticleDOI
Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial
Vivek Y. Reddy,Shephal K. Doshi,Horst Sievert,Maurice Buchbinder,Petr Neuzil,Kenneth C. Huber,Jonathan L. Halperin,David R. Holmes +7 more
TL;DR: In this article, a multicenter PROTECT AF study was conducted to determine whether percutaneous left atrial appendage closure with a filter device (Watchman) was noninferior to warfarin for stroke prevention in atrial fibrillation.
Journal ArticleDOI
Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts
Michael P. Savage,John S. Douglas,David L. Fischman,Carl J. Pepine,Spencer B. King,Jeffrey A. Werner,Steven R. Bailey,Paul Overlie,Sarah H. Fenton,Jeffrey A. Brinker,Martin B. Leon,Sheldon Goldberg,Richard R. Heuser,Richard W. Smalling,Robert D. Safian,Michael W. Cleman,Maurice Buchbinder,David Snead,Randal Rake,Sharon Gebhardt +19 more
TL;DR: Compared with balloon angioplasty, stenting of selected venous bypass-graft lesions resulted in superior procedural outcomes, a larger gain in luminal diameter, and a reduction in major cardiac events.